BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
Organoids, as three-dimensional, self-organizing tissue models, have become indispensable tools in fields such as oncology, infectious disease, developmental biology, and regenerative medicine.
Microarray technology allows the collection of increasingly larger amounts of biological data at a high level of detail. To help meet the challenges of microarray-based analysis, Grace Bio-Labs has ...
Enhancing Lateral Flow Device Design for Multiplexed Plasmonic Biosensing of Inflammatory Biomarkers
Abstract: This study investigates the enhancement of plasmonic nanoparticle-based multiplexed inflammatory biomarker detection sensitivity using a novel 3 × 3 microarray-based lateral flow device ...
NEW YORK – After going private in 2022 and rebranding in 2023, AliveDx has shifted its focus from transfusion testing to clinical testing with plans to soon launch in the US and EU an expanding menu ...
NEW YORK – Swiss firm AliveDx said Thursday that it has submitted for US Food and Drug Administration 510(k) marketing clearance a multiplex immunoassay that is used to aid the diagnosis of systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results